CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro

International Archives of Allergy and Immunology

Volumn 140, Issue SUPPL. 1, 2006, Pages 42-50

  Matsumoto, Kenji ^a   Terakawa, Maki ^a,b   Fukuda, Shuhei ^a   Kato, Atsushi ^a   Toki, Shinji ^a   Shinohara, Miwa ^a,c   Wakiguchi, Hiroshi ^c   Saito, Hirohisa ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

B cells; CpG oligodeoxynucleotide; Eosinophil; Plasmacytoid dendritic cells; Toll like receptor

Indexed keywords

ANTIBODY; ANTIGEN; BLOOD DENDRITIC CELL ANTIGEN 4; CD123 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; NEUROTOXIN; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ALLERGY; B LYMPHOCYTE; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACTIVITY; EOSINOPHIL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; SEDIMENTATION;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD19; B-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, IGG;

EID: 33745106416     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092710     Document Type: Conference Paper

References (45)

1. Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-298.
2. Krieg AM: The role of CpG motifs in innate immunity. Curr Opin Immunol 2000;12:35-43.
3. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998;95:588-593.
4. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
5. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM, Colonna M: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004;21:107-119.
6. Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004;101:11416-11421.
7. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003;198:513-520.
8. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-745.
9. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
10. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531-4537.
11. Bernasconi NL, Onai N, Lanzavecchia A: A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003;101:4500-4504.
12. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001;31:2154-2163.
13. Gursel M, Verthelyi D, Gursel I, Ishii KJ, Klinman DM: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol 2002;71:813-820.
14. Marshall JD, Fearon K, Abbate C, Subramanian S, Yee P, Gregorio J, Coffman RL, Van Nest G: Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J Leukoc Biol 2003;73:781-792.
15. Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S: Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur J Immunol 2003;33:1633-1641.
16. Liu N, Ohnishi N, Ni L, Akira S, Bacon KB: CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 2003;4:687-693.
17. Krieg AM, Efler SM, Wittpoth M, Al Adhami MJ, Davis HL: Induction of systemic Th1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J Immunother 2004;27:460-471.
18. Hayashi T, Gong X, Rossetto C, Shen C, Takabayashi K, Redecke V, Spiegelberg H, Broide D, Raz E: Induction and inhibition of the Th2 phenotype spread: implications for childhood asthma. J Immunol 2005;174:5864-5873.
19. Sano K, Shirota H: CpG oligodeoxynucleotides as a future vaccine for allergic diseases. Allergol Int 2005;54:17-23.
20. Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, Hamid Q: Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004;113:235-241.
21. Gleich GJ, Adolphson CR, Leiferman KM: The biology of the eosinophilic leukocyte. Annu Rev Med 1993;44:85-101.
22. Wardlaw AJ, Moqbel R, Kay AB: Eosinophils: biology and role in disease. Adv Immunol 1995;60:151-266.
23. Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF: Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 1998;26:3358-3363.
24. Domachowske JB, Bonville CA, Dyer KD, Rosenberg HF: Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus. Nucleic Acids Res 1998;26:5327-5332.
25. Rosenberg HF, Domachowske JB: Eosinophils, ribonucleases and host defense: solving the puzzle. Immunol Res 1999;20:261-274.
26. Meeusen EN, Balic A: Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000;16:95-101.
27. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A: Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000;164:5998-6004.
28. Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, Matsushima K, Ohta K, Yamamoto K, Hirai K: Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol 2003; 171:3977-3982.
29. Hansel TT, De VI, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C: An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
30. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39-51.
31. Matsumoto K, Terakawa M, Miura K, Fukuda S, Nakajima T, Saito H: Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro. J Immunol 2004;172:2186-2193.
32. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ: IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
33. Matsumoto K, Bochner BS, Wakiguchi H, Kurashige T: Functional expression of transmembrane 4 superfamily molecules on human eosinophils. Int Arch Allergy Immunol 1999; 120:38-44.
34. Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM: Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 2004;34:251-262.
35. Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S: Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004;5:1061-1068.
36. Kato A, Homma T, Batchelor J, Hashimoto N, Imai S, Wakiguchi H, Saito H, Matsumoto K: Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol 2003; 4:8.
37. Nakajima H, Gleich GJ, Kita H: Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996;156:4859-4866.
38. Wong CK, Wang CB, Ip WK, Tian YP, Lam CW: Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin Exp Immunol 2005;139:90-100.
39. Yamashita N, Koizumi H, Murata M, Mano K, Ohta K: Nuclear factor kappa B mediates interleukin-8 production in eosinophils. Int Arch Allergy Immunol 1999;120:230-236.
40. 40 Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M: Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994;180:711-715.
41. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK: Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002;168:4701-4710.
42. Meerschaert J, Busse WW, Bertics PJ, Mosher DF: CD14(+) cells are necessary for increased survival of eosinophils in response to lipopolysaccharide. Am J Respir Cell Mol Biol 2000; 23:780-787.
43. Blackwell SE, Krieg AM: CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha. J Immunol 2003; 170:4061-4068.
44. Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, Hartmann G: Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 2005;174:4043-4050.
45. Valerius T, Repp R, Kalden JR, Platzer E: Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 1990;145:2950-2958.